Works matching AU Pomykala, Kelsey L.

Results: 24

Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times.

Published in:

European Radiology, 2023, v. 33, n. 9, p. 6179, doi. 10.1007/s00330-023-09580-6

By:

Jannusch, Kai;
Lindemann, Maike E.;
Bruckmann, Nils Martin;
Morawitz, Janna;
Dietzel, Frederic;
Pomykala, Kelsey L.;
Herrmann, Ken;
Bittner, Ann-Kathrin;
Hoffmann, Oliver;
Mohrmann, Svjetlana;
Umutlu, Lale;
Antoch, Gerald;
Quick, Harald H.;
Kirchner, Julian

Publication type:

Article

Simultaneous multislice diffusion-weighted imaging versus standard diffusion-weighted imaging in whole-body PET/MRI.

Published in:

European Radiology, 2023, v. 33, n. 4, p. 2536, doi. 10.1007/s00330-022-09275-4

By:

Furtado, Felipe S.;
Mercaldo, Nathaniel D.;
Vahle, Thomas;
Benkert, Thomas;
Bradley, William R.;
Ratanaprasatporn, Lisa;
Seethamraju, Ravi Teja;
Harisinghani, Mukesh G.;
Lee, Susanna;
Suarez-Weiss, Krista;
Umutlu, Lale;
Catana, Ciprian;
Pomykala, Kelsey L.;
Domachevsky, Liran;
Bernstine, Hanna;
Groshar, David;
Rosen, Bruse R.;
Catalano, Onofrio Antonio

Publication type:

Article

Oncologic Staging with 68Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than 18F-FDG PET/CT.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1906, doi. 10.2967/jnumed.123.265751

By:

Demmert, Tristan T.;
Pomykala, Kelsey L.;
Lanzafame, Helena;
Pabst, Kim M.;
Lueckerath, Katharina;
Siveke, Jens;
Umutlu, Lale;
Hautzel, Hubertus;
Hamacher, Rainer;
Herrmann, Ken;
Fendler, Wolfgang P.

Publication type:

Article

Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with 90Y Glass Microspheres.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 7, p. 1102, doi. 10.2967/jnumed.122.264996

By:

Watanabe, Masao;
Grafe, Hong;
Theysohn, Jens;
Schaarschmidt, Benedikt;
Ludwig, Johannes;
Jochheim, Leonie;
Jeschke, Matthias;
Schmidt, Hartmut;
Fendler, Wolfgang P.;
Moraitis, Alexandres;
Herrmann, Ken;
Pomykala, Kelsey L.;
Weber, Manuel

Publication type:

Article

Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 685, doi. 10.2967/jnumed.122.265353

By:

Feuerecker, Benedikt;
Kratochwil, Clemens;
Ahmadzadehfar, Hojjat;
Morgenstern, Alfred;
Eiber, Matthias;
Herrmann, Ken;
Pomykala, Kelsey L.

Publication type:

Article

Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 347, doi. 10.2967/jnumed.122.264900

By:

Pomykala, Kelsey L.;
Würker, Marcus;
Herrmann, Ken

Publication type:

Article

Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Prostate Cancer: We have the answers.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264394

By:

Pomykala, Kelsey L.;
Herrmann, Ken;
Padhani, Anwar R.;
Hofman, Michael S.;
Lalumera, Elisabetta;
Fanti, Stefano

Publication type:

Article

Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Prostate Cancer: We have the answers.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264394

By:

Pomykala, Kelsey L.;
Herrmann, Ken;
Padhani, Anwar R.;
Hofman, Michael S.;
Lalumera, Elisabetta;
Fanti, Stefano

Publication type:

Article

Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Prostate Cancer: We have the answers.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.264394

By:

Pomykala, Kelsey L.;
Herrmann, Ken;
Padhani, Anwar R.;
Hofman, Michael S.;
Lalumera, Elisabetta;
Fanti, Stefano

Publication type:

Article

Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Prostate Cancer: We have the answers.

Published in:

Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264394

By:

Pomykala, Kelsey L.;
Herrmann, Ken;
Padhani, Anwar R.;
Hofman, Michael S.;
Lalumera, Elisabetta;
Fanti, Stefano

Publication type:

Article

Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.245803

By:

Ferdinandus, Justin;
Barbato, Francesco;
Chodyla, Michal;
Fendler, Wolfgang P.;
Kessler, Lukas;
Pomykala, Kelsey L.;
Metzenmacher, Martin;
Krefting, Frederik;
Hager, Thomas;
Umutlu, Lale;
Herrmann, Ken;
Christoph, Daniel C.

Publication type:

Article

Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.245803

By:

Ferdinandus, Justin;
Barbato, Francesco;
Chodyla, Michal;
Fendler, Wolfgang P.;
Kessler, Lukas;
Pomykala, Kelsey L.;
Metzenmacher, Martin;
Krefting, Frederik;
Hager, Thomas;
Umutlu, Lale;
Herrmann, Ken;
Christoph, Daniel C.

Publication type:

Article

Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.245803

By:

Ferdinandus, Justin;
Barbato, Francesco;
Chodyla, Michal;
Fendler, Wolfgang P;
Kessler, Lukas;
Pomykala, Kelsey L;
Metzenmacher, Martin;
Krefting, Frederik;
Hager, Thomas;
Umutlu, Lale;
Herrmann, Ken;
Christoph, Daniel C

Publication type:

Article

Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.245803

By:

Ferdinandus, Justin;
Barbato, Francesco;
Chodyla, Michal;
Fendler, Wolfgang P.;
Kessler, Lukas;
Pomykala, Kelsey L.;
Metzenmacher, Martin;
Krefting, Frederik;
Hager, Thomas;
Umutlu, Lale;
Herrmann, Ken;
Christoph, Daniel C.

Publication type:

Article

Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.

Published in:

Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.245803

By:

Ferdinandus, Justin;
Barbato, Francesco;
Chodyla, Michal;
Fendler, Wolfgang P.;
Kessler, Lukas;
Pomykala, Kelsey L.;
Metzenmacher, Martin;
Krefting, Frederik;
Hager, Thomas;
Umutlu, Lale;
Herrmann, Ken;
Christoph, Daniel C.

Publication type:

Article

Total-body 68Ga-PSMA-11 PET/CT for bone metastasis detection in prostate cancer patients: Potential Impact on bone scan guidelines.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.230318

By:

Pomykala, Kelsey L.;
Czernin, Johannes;
Grogan, Tristan R.;
Armstrong, Wesley R.;
Williams, John;
Calais, Jeremie

Publication type:

Article

Perceived Misinterpretation Rates in Oncologic 18F-FDG PET/CT Studies: A Survey of Referring Physicians.

Published in:

Journal of Nuclear Medicine, 2014, v. 55, n. 12, p. 1925, doi. 10.2967/jnumed.114.145607

By:

Karantanis, Dimitrios;
Kalkanis, Dimitrios;
Czernin, Johannes;
Herrmann, Ken;
Pomykala, Kelsey L.;
Bogsrud, Trond V.;
Subramaniam, Rathan M.;
Lowe, Val J.;
Allen-Auerbach, Martin S.

Publication type:

Article

"A net for everyone": fully personalized and unsupervised neural networks trained with longitudinal data from a single patient.

Published in:

BMC Medical Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12880-023-01128-w

By:

Strack, Christian;
Pomykala, Kelsey L.;
Schlemmer, Heinz-Peter;
Egger, Jan;
Kleesiek, Jens

Publication type:

Article

The future of radiosynoviorthesis: bright or bleak?

Published in:

Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 66, n. 4, p. 345, doi. 10.23736/S1824-4785.22.03475-6

By:

FREUDENBERG, Lutz S.;
SEWERIN, Phillipp;
OHLERTH, Stefanie M.;
POMYKALA, Kelsey L.;
FREUDENBERG, Stefanie;
RISCHPLER, Christoph;
LÜTZEN, Ulf

Publication type:

Article

Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [68Ga]Ga-/[18F]F-PSMA-11/-1007, [68Ga]Ga-FAPI-46 and 2-[18F]FDG PET/CT: a pilot study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 342, doi. 10.1007/s00259-024-06891-8

By:

Pabst, Kim M.;
Mei, Riccardo;
Lückerath, Katharina;
Hadaschik, Boris A.;
Kesch, Claudia;
Rawitzer, Josefine;
Kessler, Lukas;
Bodensieck, Luisa S.;
Hamacher, Rainer;
Pomykala, Kelsey L.;
Fanti, Stefano;
Herrmann, Ken;
Fendler, Wolfgang P.

Publication type:

Article

Evaluation of thresholding methods for the quantification of [68Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [177Lu]Lu-PSMA-617 radioligand therapy

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 2196, doi. 10.1007/s00259-023-06163-x

By:

Kim, Moon;
Seifert, Robert;
Fragemann, Jana;
Kersting, David;
Murray, Jacob;
Jonske, Frederic;
Pomykala, Kelsey L.;
Egger, Jan;
Fendler, Wolfgang P.;
Herrmann, Ken;
Kleesiek, Jens

Publication type:

Article

(18) F-Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.

Published in:

2013

By:

Al-Ibraheem, Akram;
Buck, Andreas K;
Benz, Matthias R;
Rudert, Maximilian;
Beer, Ambros J;
Mansour, Asem;
Pomykala, Kelsey L;
Haller, Bernhard;
Juenger, Hendrik;
Scheidhauer, Klemens;
Schwaiger, Markus;
Herrmann, Ken

Publication type:

Journal Article

18F-Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.

Published in:

Cancer (0008543X), 2013, v. 119, n. 6, p. 1227, doi. 10.1002/cncr.27866

By:

Al‐Ibraheem, Akram;
Buck, Andreas K.;
Benz, Matthias R.;
Rudert, Maximilian;
Beer, Ambros J.;
Mansour, Asem;
Pomykala, Kelsey L.;
Haller, Bernhard;
Juenger, Hendrik;
Scheidhauer, Klemens;
Schwaiger, Markus;
Herrmann, Ken

Publication type:

Article

Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients.

Published in:

Neuro-Oncology, 2014, v. 16, n. 4, p. 603, doi. 10.1093/neuonc/not166

By:

Herrmann, Ken;
Czernin, Johannes;
Cloughesy, Timothy;
Lai, Albert;
Pomykala, Kelsey L.;
Benz, Matthias R.;
Buck, Andreas K.;
Phelps, Michael E.;
Chen, Wei

Publication type:

Article

Works matching AU Pomykala, Kelsey L.

Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times.

Simultaneous multislice diffusion-weighted imaging versus standard diffusion-weighted imaging in whole-body PET/MRI.

Oncologic Staging with <sup>68</sup>Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than <sup>18</sup>F-FDG PET/CT.

Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with <sup>90</sup>Y Glass Microspheres.

Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?

Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy.

Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Prostate Cancer: We have the answers.

Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Prostate Cancer: We have the answers.

Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Prostate Cancer: We have the answers.

Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Prostate Cancer: We have the answers.

Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.

Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.

Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.

Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.

Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.

Total-body 68Ga-PSMA-11 PET/CT for bone metastasis detection in prostate cancer patients: Potential Impact on bone scan guidelines.

Perceived Misinterpretation Rates in Oncologic <sup>18</sup>F-FDG PET/CT Studies: A Survey of Referring Physicians.

"A net for everyone": fully personalized and unsupervised neural networks trained with longitudinal data from a single patient.

The future of radiosynoviorthesis: bright or bleak?

Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [<sup>68</sup>Ga]Ga-/[<sup>18</sup>F]F-PSMA-11/-1007, [<sup>68</sup>Ga]Ga-FAPI-46 and 2-[<sup>18</sup>F]FDG PET/CT: a pilot study.

Evaluation of thresholding methods for the quantification of [<sup>68</sup>Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy

(18) F-Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.

<sup>18</sup>F-Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.

Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients.